Current status of treatment for osteosarcoma of head and neck
10.3760/cma.j.issn.1004-4221.2019.10.014
- VernacularTitle: 头颈部骨肉瘤治疗现状
- Author:
Zhiping LIU
1
;
Daxin ZHANG
;
Jie PAN
;
Yisi ZHANG
Author Information
1. Department of Oncology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
- Publication Type:Review
- Keywords:
Osteosarcoma/radiotherapy;
Osteosarcoma/chemotherapy;
Osteosarcoma/other therapy
- From:
Chinese Journal of Radiation Oncology
2019;28(10):780-783
- CountryChina
- Language:Chinese
-
Abstract:
Head and neck osteosarcoma is a rare tumor. Its clinical features and recurrence pattern are different from those of osteosarcoma in other parts. Osteosarcoma of the head and neck occurs late with a high local recurrence rate and a low distant metastasis rate. Local recurrence is the main cause of death. Surgery is the main treatment. Postoperative radiotherapy is recommended for patients with positive surgical margin, proximal incisional margin and uncertain surgical margin. The role of chemotherapy remains controversial. Effective molecular targeted therapeutics need to be further explored for recurrent, metastatic and unresectable osteosarcoma, .
